Cover Image
市場調查報告書

生物晶片的全球市場 - 2020年:各種類 (DNA晶片、實驗室晶片、蛋白質晶片)、終端用戶、製造技術 (微陣列、微流體)、地區

Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user, Fabrication Technology (Microarrays, Microfluidics) - Forecast to 2020

出版商 MarketsandMarkets 商品編碼 209170
出版日期 內容資訊 英文 171 Pages
訂單完成後即時交付
價格
Back to Top
生物晶片的全球市場 - 2020年:各種類 (DNA晶片、實驗室晶片、蛋白質晶片)、終端用戶、製造技術 (微陣列、微流體)、地區 Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user, Fabrication Technology (Microarrays, Microfluidics) - Forecast to 2020
出版日期: 2016年05月03日 內容資訊: 英文 171 Pages
簡介

生物晶片市場,預計從2015年的76億3千萬美元,到2020年擴大到177億5千萬美元。市場預計2015年∼2020年以18.4%的高成長預計。

本報告提供全球生物晶片市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 生物晶片市場概要
  • 生物晶片市場:各用途、終端用戶
  • 生物晶片市場:各地區概述
  • 生物晶片市場:各類型
  • 生物晶片市場:各終端用戶
  • 生物晶片市場:各製造技術

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 生物晶片市場:各類型

  • 簡介
  • DNA晶片
  • 實驗室晶片 (LOC)
  • 蛋白質晶片
  • 其他

第7章 生物晶片市場:各製造技術

  • 簡介
  • 微陣列
  • 微流體

第8章 生物晶片市場:各終端用戶

  • 簡介
  • 生物科技企業,製藥公司
  • 醫院,診斷中心
  • 學術、研究機關
  • 其他

第9章 生物晶片市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

  • 概要
  • 競爭情形與趨勢

第11章 企業簡介 (概要,財務,產品與服務,策略,發展)

  • 簡介
  • ABBOTT LABORATORIES
  • AGILENT TECHNOLOGIES, INC.
  • PERKINELMER, INC.
  • FLUIDIGM CORPORATION
  • ILLUMINA, INC.
  • GE HEALTHCARE
  • BIO-RAD LABORATORIES INC.
  • CEPHEID INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • ROCHE DIAGNOSTICS

第12章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 4275

Growing Applications of Biochips and Technological Advancements Will Boost the Growth of the Biochips Market

The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015-2020). A biochip is an assembly of miniaturized test sites arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput.

In this report, the biochips market is segmented on the basis of type, application, fabrication technology, end user, and region. Based on type, the market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. The other arrays segment includes cell arrays and tissue arrays.

Based on end users, the biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.

Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are the major drivers for the biochips market. However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent. On the other hand, developing countries are expected to offer significant growth opportunities for players operating in the biochips market.

PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in the biochips market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the biochips market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top players in the global biochips market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the biochips market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for biochips across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global biochips market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the biochips market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
    • 2.2.3. KEY INDUSTRY INSIGHTS
    • 2.2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOCHIPS MARKET OVERVIEW
  • 4.2. BIOCHIPS MARKET: BY APPLICATION AND END USER
  • 4.3. BIOCHIPS MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. BIOCHIPS MARKET: BY TYPE
  • 4.5. BIOCHIPS MARKET: BY END USER
  • 4.6. BIOCHIPS MARKET: BY FABRICATION TECHNOLOGY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY TYPE AND APPLICATION
    • 5.2.2. BY FABRICATION TECHNOLOGY
    • 5.2.3. BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing adoption of personalized medicine
      • 5.3.1.2. Growing applications of biochips
      • 5.3.1.3. Technological advancements
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Unclear regulatory guidelines
      • 5.3.2.2. High instrumentation costs
      • 5.3.2.3. Absolute quantification of specific mRNA expressions
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Significant growth prospects in developing countries
      • 5.3.3.2. Biochip technology, a safe and economical alternative to animal testing
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Complexity of biological systems

6. BIOCHIPS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. DNA CHIPS
    • 6.2.1. DNA CHIPS MARKET, BY APPLICATION
      • 6.2.1.1. Gene expression
      • 6.2.1.2. SNP Genotyping
      • 6.2.1.3. Cancer Diagnosis & Treatment
      • 6.2.1.4. Genomics
      • 6.2.1.5. Drug Discovery
      • 6.2.1.6. Agricultural Biotechnology
      • 6.2.1.7. Other DNA Chip Applications
  • 6.3. LAB-ON-A-CHIP
    • 6.3.1. LAB-ON-A-CHIP MARKET, BY APPLICATION
      • 6.3.1.1. Clinical Diagnostics
      • 6.3.1.2. Genomics
      • 6.3.1.3. IVD & POC
      • 6.3.1.4. Proteomics
      • 6.3.1.5. Drug Discovery
      • 6.3.1.6. Other LOAC Applications Market
  • 6.4. PROTEIN CHIPS
    • 6.4.1. PROTEIN CHIPS MARKET, BY APPLICATIONS
      • 6.4.1.1. Proteomics
      • 6.4.1.2. Expression Profiling
      • 6.4.1.3. Diagnostics
      • 6.4.1.4. High-throughput Screening
      • 6.4.1.5. Drug Discovery
      • 6.4.1.6. Other Applications
  • 6.5. OTHER ARRAYS
    • 6.5.1. CELL ARRAYS
    • 6.5.2. TISSUE ARRAYS

7. BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. MICROARRAYS
  • 7.3. MICROFLUIDICS

8. BIOCHIPS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
  • 8.3. HOSPITALS AND DIAGNOSTICS CENTERS
  • 8.4. ACADEMIC & RESEARCH INSTITUTES
  • 8.5. OTHERS

9. BIOCHIPS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
  • 9.3. EUROPE
  • 9.4. ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SITUATION AND TRENDS
    • 10.2.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.2.2. ACQUISITIONS
    • 10.2.3. PRODUCT LAUNCHES AND ENHANCEMENTS
    • 10.2.4. EXPANSIONS
    • 10.2.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 11.1. INTRODUCTION
  • 11.2. ABBOTT LABORATORIES
  • 11.3. AGILENT TECHNOLOGIES, INC.
  • 11.4. PERKINELMER, INC.
  • 11.6. FLUIDIGM CORPORATION
  • 11.7. ILLUMINA, INC.
  • 11.8. GE HEALTHCARE
  • 11.9. BIO-RAD LABORATORIES INC.
  • 11.10. CEPHEID INC.
  • 11.12. THERMO FISHER SCIENTIFIC, INC.
  • 11.13. ROCHE DIAGNOSTICS

*Details might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING ADOPTION OF PERSONALIZED MEDICINE, A KEY DRIVER FOR THE GROWTH OF THE BIOCHIPS MARKET
  • TABLE 2: REGULATORY HURDLES TO LIMIT MARKET GROWTH DURING THE FORECAST PERIOD
  • TABLE 3: LUCRATIVE OPPORTUNITIES IN DEVELOPING COUNTRIES MAY BOOST MARKET GROWTH
  • TABLE 4: COMPLEXITY OF BIOLOGICAL SYSTEMS MAY HAMPER THE GROWTH OF THE MARKET
  • TABLE 5: BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 6: DNA CHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 8: GENE EXPRESSION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: SNP GENOTYPING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: CANCER DIAGNOSIS AND TREATMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: GENOMICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: DRUG DISCOVERY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: OTHER DNA CHIP APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: LAB-ON-A-CHIP MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: LAB-ON-A-CHIP MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 17: CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: GENOMICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: IVD AND POC MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: PROTEOMICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: DRUG DISCOVERY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: OTHER LOC SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 24: PROTEIN CHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: PROTEOMICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: EXPRESSION PROFILING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: DRUG DISCOVERY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: OTHER PROTEIN MICROARRAY APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: OTHER ARRAYS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 32: OTHER ARRAYS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: CELL ARRAYS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: TISSUE ARRAYS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: BIOCHIP MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 36: MICROARRAYS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: MICROFLUIDICS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: BIOCHIPS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 39: BIOCHIPS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: BIOCHIPS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: BIOCHIPS MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: BIOCHIPS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 48: NORTH AMERICA: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 49: NORTH AMERICA: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 50: NORTH AMERICA: BIOCHIPS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 51: EUROPE: BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPE: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 57: EUROPE: BIOCHIPS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 69: ROW: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 70: ROW: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 71: ROW: BIOCHIPS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 72: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 73: ACQUISITIONS, 2013-2015
  • TABLE 74: PRODUCT LAUNCHES AND ENHANCEMENTS, 2013-2015
  • TABLE 75: EXPANSIONS, 2013-2015
  • TABLE 76: OTHER DEVELOPMENTS, 2013-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION AND DATA TRIANGULATION
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
  • FIGURE 4: BIOCHIPS MARKET SNAPSHOT, 2015 VS. 2020
  • FIGURE 5: DNA CHIPS SEGMENT WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020
  • FIGURE 6: MICROFLUIDICS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 7: HOSPITALS AND DIAGNOSTICS CENTERS SEGMENT DOMINATED THE BIOCHIPS END-USER MARKET IN 2015
  • FIGURE 8: GEOGRAPHICAL SNAPSHOT OF THE BIOCHIPS MARKET, 2015
  • FIGURE 9: INCREASED ADOPTION OF PERSONALISED MEDICINE TO DRIVE THE BIOCHIPS MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 10: DNA CHIPS TO DOMINATE THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 11: ASIA-PACIFIC TO REGISTER HIGHEST GROWTH FROM 2015 TO 2020
  • FIGURE 12: LAB-ON-A-CHIP SEGMENT TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020
  • FIGURE 13: HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE BIOCHIPS END-USER MARKET IN 2015
  • FIGURE 14: HIGH GROWTH POTENTIAL IN THE MICROFLUIDICS FABRICATION TECHNOLOGY MARKET
  • FIGURE 15: BIOCHIPS MARKET SEGMENTATION, BY TYPE AND APPLICATION
  • FIGURE 16: BIOCHIPS MARKET SEGMENTATION, BY FABRICATION TECHNOLOGY
  • FIGURE 17: BIOCHIPS MARKET SEGMENTATION, BY END USER
  • FIGURE 18: BIOCHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
  • FIGURE 19: ONCOLOGY TREATMENT OPTIONS MARKET SHARE, 2003 VS. 2013
  • FIGURE 20: LOCAL VS. MULTINATIONAL CLINICAL STUDIES, 2015
  • FIGURE 21: DNA BIOCHIPS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL BIOCHIPS MARKET, BY TYPE, IN 2015
  • FIGURE 22: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OVERALL DNA CHIPS MARKET, BY REGION, DURING THE FORECAST PERIOD
  • FIGURE 23: CANCER DIAGNOSIS AND TREATMENT ACCOUNTED FOR THE LARGEST SHARE OF DNA CHIPS MARKET, BY APPLICATION, IN 2015
  • FIGURE 24: ASIA-PACIFIC IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE IN THE GENE EXPRESSION MARKET, BY REGION, DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SNP GENOTYPING MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: ASIA-PACIFIC IS EXPECTED TO ACCOUNT FOR HIGHEST GROWTH RATE OF THE CANCER DIAGNOSIS AND TREATMENT MARKET, BY REGION, DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS MARKET, BY TYPE, IN 2015
  • FIGURE 28: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET, BY REGION, DURING THE FORECAST PERIOD
  • FIGURE 29: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION, DURING THE FORECAST PERIOD
  • FIGURE 30: CLINICAL DIAGNOSTICS ACCOUNTED FOR THE LARGEST SHARE OF THE LAB-ON-A-CHIP MARKET, BY APPLICATION, IN 2015
  • FIGURE 31: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE CLINICAL DIAGNOSTICS MARKET, BY REGION, DURING THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS MARKET, BY REGION, IN 2015
  • FIGURE 33: ASIA-PACIFIC TO REGISTER HIGHEST GROWTH IN THE IVD AND POC MARKET, BY REGION DURING THE FORECAST PERIOD
  • FIGURE 34: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEOMICS MARKET, BY REGION, IN 2015
  • FIGURE 35: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET, BY REGION DURING THE FORECAST PERIOD
  • FIGURE 36: PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEIN CHIPS MARKET, BY APPLICATION, IN 2015
  • FIGURE 37: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEOMICS MARKET, BY REGION, IN 2015
  • FIGURE 38: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE EXPRESSION PROFILING MARKET DURING THE FORECAST PERIOD
  • FIGURE 39: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE DIAGNOSTICS MARKET, BY REGION, IN 2015
  • FIGURE 40: ASIA-PACIFIC MARKET WILL REGISTER THE FASTEST GROWTH IN THE HTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 41: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE DRUG DISCOVERY MARKET, BY REGION, IN 2015
  • FIGURE 42: TISSUE ARRAYS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL OTHER ARRAYS MARKET, BY TYPE, IN 2015
  • FIGURE 43: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OTHER ARRAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 44: MICROARRAYS WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020
  • FIGURE 45: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF MICROARRAYS MARKET IN 2015
  • FIGURE 46: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN MICROFLUIDICS IN BIOCHIPS MARKET
  • FIGURE 47: HOSPITALS AND DIAGNOSTIC CENTERS ARE THE MAJOR END USERS OF THE BIOCHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 48: NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES DURING THE FORECAST PERIOD
  • FIGURE 49: ASIA-PACIFIC OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR BIOCHIPS MARKET FOR HOSPITALS AND DIAGNOSTICS CENTERS DURING THE FORECAST PERIOD
  • FIGURE 50: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE OTHER END USERS MARKET IN 2015
  • FIGURE 51: GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE BIOCHIPS MARKET BY 2020
  • FIGURE 52: ASIA-PACIFIC MARKET FOR BIOCHIPS SHOWS SIGNIFICANT GROWTH OPPORTUNITIES
  • FIGURE 53: NORTH AMERICA WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 54: NORTH AMERICA: BIOCHIPS MARKET SNAPSHOT 2015-2020
  • FIGURE 55: GENE EXPRESSION SEGMENT TO SHOW HIGHEST GROWTH IN THE NORTH AMERICAN DNA CHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 56: PROTEOMICS WILL CONTINUE TO LEAD THE NORTH AMERICAN PROTEIN CHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 57: HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 58: DNA CHIPS WILL CONTINUE TO DOMINATE THE EUROPEAN BIOCHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 59: GENE EXPRESSION APPLICATION SEGMENT OF THE EUROPEAN DNA CHIPS MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 60: HOSPITAL AND DIAGNOSTICS CENTERS END-USER SEGMENT WILL CONTINUE TO DOMINATE THE EUROPEAN MARKET DURING THE FORECAST PERIOD
  • FIGURE 61: ASIA-PACIFIC BIOCHIPS MARKET SNAPSHOT 2015-2020
  • FIGURE 62: GENE EXPRESSION SEGMENT WILL CONTINUE TO LEAD THE ASIA-PACIFIC DNA CHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 63: PROTEOMICS HOLDS HIGHEST SHARE IN THE ASIA-PACIFIC PROTEIN CHIPS MARKET IN 2015
  • FIGURE 64: HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 65: DNA CHIPS WILL CONTINUE TO HOLD THE HIGHEST SHARE IN THE ROW BIOCHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 66: HOSPITAL AND DIAGNOSTICS CENTERS WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 67: ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2013-2016
  • FIGURE 68: ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS- KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN BIOCHIPS MARKET
  • FIGURE 69: GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
Back to Top